We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $100.92 · 25 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Why Is Ionis Pharmaceuticals (IONS) Up 3.4% Since Last Earnings Report? - Yahoo Finance
Why Is Ionis Pharmaceuticals (IONS) Up 3.4% Since Last Earnings Report? Yahoo Finance
Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance - Yahoo Finance
Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance Yahoo Finance
Ionis Pharmaceuticals (IONS) Earnings Report Q3 2025 | Beat, EPS & Revenue - 24/7 Wall St.
Ionis Pharmaceuticals (IONS) Earnings Report Q3 2025 | Beat, EPS & Revenue 24/7 Wall St.
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $-0.87 | — | — | $189.64M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.93 | — | — | $131.61M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-2.38 | — | — | $478.56M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-1.43 | — | — | $344.75M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 19. | Citigroup | — | Initiate coverage | — → Buy | — | Citigroup: Buy |
| 2026. 05. 01. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
Compare a firm's past rating changes and its actions on other stocks in the same sector.
As of FY2026Q1 · Source: SEC/DART + price data
Filings, earnings, and institutional changes summarized in one paragraph, with source links.
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 5,857,629 | $439.85B | 0.38% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 2,658,646 | $210.33B | 0.33% | — | New position |
See new positions, full exits, and weight changes.